Article

Broad Expression of Toll-Like Receptors in the Human Central Nervous System

Division of Immunological and Infectious Diseases, TNO Prevention and Health, Leiden, The Netherlands.
Journal of Neuropathology and Experimental Neurology (Impact Factor: 3.8). 12/2002; 61(11):1013-21. DOI: 10.1093/jnen/61.11.1013
Source: PubMed

ABSTRACT

The family of Toll-like receptors (TLRs) plays a key role in controlling innate immune responses to a wide variety of pathogen-associated molecules. In this study we investigated expression of TLRs in vitro by purified human microglia, astrocytes, and oligodendrocytes, and in vivo by immunohistochemical examination of brain and spinal cord sections. Cultured primary microglia were found to express mRNA encoding a wide range of different TLR family members while astrocytes and oligodendrocytes primarily express TLR2 and TLR3. Comparisons between microglia derived from a series of control subjects and neurodegenerative cases indicate distinct differences in levels of mRNA encoding the different TLRs indifferent microglia samples. Interestingly, expression of TLR proteins in cultured microglia as revealed by immunocytochemistry was restricted to intracellular vesicles, whereas in astrocytes they were exclusively localized on the cell surface. Finally, in vivo expression of TLR3 and TLR4 was examined by immunohistochemical analysis of brain and spinal cord sections from both control and multiple sclerosis brains, revealing enhanced expression of either TLR in inflamed CNS tissues. Together, our data reveal broad and regulated expression of TLRs both in vitro and in vivo by human glia cells.

Download full-text

Full-text

Available from: Rivka Ravid
  • Source
    • "The recognition of such molecules is enabled by the astrocytic expression of specific pattern-recognition receptors, including various members of the toll-like receptor (TLR) family [1] [2] [6]. Studies in vitro and in human postmortem tissues consistently reported low but detectable astrocytic expression of TLR4 [7] [8] [9] [10], a receptor that confers cellular responsiveness to the endotoxin lipopolysaccharide (LPS), an integral component of the outer membranes of Gram-negative bacteria [11] [12] [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several lines of evidence suggest that astrocytes play a key role in modulating the immune responses of the central nervous system (CNS) to infections, injuries, or pathologies. Yet, their contribution to these processes remains mostly elusive. Astroglia are endowed with a wide range of toll-like receptors (TLR) by which they can sense infectious agents as well as endogenous danger signals released by damaged cells. Here we demonstrate that the activation of astrocytic TLR4 by bacterial lipopolysaccharide (LPS) challenge can promote nuclear factor κB (NF-κB)-dependent induction of pro-inflammatory and stress response mediators, particularly Tumor Necrosis Factor α (TNFα), cyclooxygenase 2 (COX-2), and inducible nitric oxide synthase (iNOS). Since the steroid lactone Withaferin A was described to inhibit NF-κB activity in different cell types, we next determined the impact of this natural compound towards the identified astrocytic signalling pathway. Innate immune activation was induced by stimulation of the LPS/TLR4 axis in spinal cord astrocytes. We provide evidence that both pre-treating and post-treating the cells with Withaferin A attenuate astrocytic NF-κB activity as well as the consequent production of TNFα, COX-2, and iNOS induced by stimulation of the LPS/TLR4 pathway. This study suggests that Withaferin A may be an eligible candidate for the treatment of neuroinflammatory and stress conditions characterized by an important astrocytic input.
    Full-text · Article · Aug 2015 · Neural Plasticity
  • Source
    • "An additional consideration for dissecting the role of TLR4 in AD is the cell-and species-specific expression. Although microglia express functional TLR4, data are conflicting on the expression and activity of TLR4 in isolated astrocyte cultures (Bsibsi et al. 2002; Lehnardt et al. 2002; Sola et al. 2002; Bowman et al. 2003; Falsig et al. 2004; Carpentier et al. 2005). One confounding factor is the purity of the in vitro cultures, as contaminating microglia may be responsible for the TLR4 agonist-induced proinflammatory cytokine secretion directly, and/or through activating astrocytes via paracrine-like signaling. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic glial activation and neuroinflammation induced by the amyloid-β peptide (Aβ) contribute to Alzheimer's disease (AD) pathology. APOE4 is the greatest AD-genetic risk factor; increasing risk up to 12-fold compared to APOE3, with APOE4-specific neuroinflammation an important component of this risk. This editorial review discusses the role of APOE in inflammation and AD, via a literature review, presentation of novel data on Aβ-induced neuroinflammation, and discussion of future research directions. The complexity of chronic neuroinflammation, including multiple detrimental and beneficial effects occurring in a temporal and cell-specific manner, has resulted in conflicting functional data for virtually every inflammatory mediator. Defining a neuroinflammatory phenotype (NIP) is one way to address this issue, focusing on profiling the changes in inflammatory mediator expression during disease progression. Although many studies have shown that APOE4 induces a detrimental NIP in peripheral inflammation and Aβ-independent neuroinflammation, data for APOE-modulated Aβ-induced neuroinflammation are surprisingly limited. We present data supporting the hypothesis that impaired apoE4 function modulates Aβ-induced effects on inflammatory-receptor signaling, including amplification of detrimental (TLR4-p38α) and suppression of beneficial (IL-4R-nuclear receptor) pathways. To ultimately develop APOE genotype-specific therapeutics, it is critical that future studies define the dynamic NIP profile and pathways that underlie APOE-modulated chronic neuroinflammation. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Full-text · Article · Feb 2015 · Journal of Neurochemistry
    • "TLRs are thus essential components in the initiation of the innate immune response to microbes and tissue damage. TLRs are expressed by a variety of immune-related cells (Eriksson et al., 2006; Gerondakis et al., 2007; Iwamura and Nakayama, 2008; Kaisho and Akira, 2006; Sabroe and Whyte, 2007; Sutmuller et al., 2007; Yoshimoto and Nakanishi, 2006) as well as brain residing cells (Gibson et al., 2008; Yoshimoto and Nakanishi, 2006) such as microglia (Olson and Miller, 2004), astrocytes (Bowman et al., 2003), oligodendrocytes (Tang et al., 2007b) and neurons (Bsibsi et al., 2002). TLR activation relies on receptor dimerization (Kawai and Akira, 2007) and multimerization (Bell et al., 2005; de Bouteiller et al., 2005) to achieve specificity in ligand recognition. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Accumulating evidence indicates that aging is associated with a chronic low-level inflammation, termed sterile-inflammation. Sterile-inflammation is a form of pathogen-free inflammation caused by mechanical trauma, ischemia, stress or environmental conditions such as ultra-violet radiation. These damage-related stimuli induce the secretion of molecular agents collectively termed danger-associated molecular patterns (DAMPs). DAMPs are recognized by virtue of specialized innate immune receptors, such as toll-like receptors (TLRs) and NOD-like receptor family, pyrin domain containing 3 (NLRP3). These receptors initiate signal transduction pathways, which typically drive inflammation in response to microbe-associated molecular patterns (MAMPs) and/or DAMPs. This review summarizes the current knowledge on DAMPs-mediated sterile-inflammation, its associated downstream signaling, and discusses the possibility that DAMPs activating TLRs or NLRP3 complex mediate sterile inflammation during aging and in aging-related pathologies. Copyright © 2015. Published by Elsevier B.V.
    No preview · Article · Jan 2015 · Ageing Research Reviews
Show more